State candidate definition

State candidate means a candidate who seeks nomination or election to any elective state office.
Sample 1Sample 2Sample 3
State candidate means a candidate seeking nomination or election to any elective state office.
Sample 1
State candidate means a candidate seeking nomination or election to an elective state office.
Sample 1

Examples of State candidate in a sentence

  • Payments by a State can- didate or his or her campaign com- mittee to a State or local political party committee for the State can- didate’s share of expenses for such campaign materials are not contribu- tions, provided the amount paid by the State candidate or his or her com- mittee does not exceed his or her pro- portionate share of the expenses.

  • Payments by a State can- didate or his or her campaign com- mittee to a State or local political party committee for the State can- didate’s share of expenses for such campaign materials are not expendi- tures, provided the amount paid by the State candidate or his or her com- mittee does not exceed his or her pro- portionate share of the expenses.

  • The exception to this rule is for a business entity that:• Does public business involving consideration of $200,000 or more for a single contract (see Title 14 of the Election Law Article); or• Employs a registered lobbyist for compensation in excess of $500 during the reporting period (see § 5-716 of the General Provisions Article) and makes contributions or donations to or on behalf of a State candidate in the cumulative amount of $500 or more during a reporting period.

  • A letter of certification signed by the Council Chairman and Council Secretary certifying the name of the endorsed State candidate for International Director or Second Vice-President shall be sent to the International Office in accordance with the requirements set forth in the International Constitution and Bylaws.

  • On the Democratic side, army veteran and 2022 Secretary of State candidate Destiny Wells and nonprofit executive and former Marion County Clerk Beth White have both announced their candidacies.

  • Willapa Bay and Grays Harbor comprise the current known distribution in Washington of Newcomb’s Littorine Snail (Littorina subrotunda), a federal species of concern and a Washington State candidate species.

  • Criminal assistance cases are cases within the legal competence of OLAF in which the competent authorities of a Member State, candidate country or non-EU country carry out a criminal investigation and request OLAF’s assistance or OLAF offers its assistance.

  • Payments by a State candidate or his or her campaign committee to a State or local political party committee for the State candidate’s share of expenses for such campaign materials are not expenditures, provided the amount paid by the State candidate or his or her committee does not exceed his or her proportionate share of the expenses.

  • These activities are their main source of livelihoods, they are a source of pride and cultural identity despite their difficulties and threats that must face because of climate change.

  • The issue concerns the following provision in Article II of Maine’s Constitution on the timing of State candidate elections: Section 4.

Related to State candidate

  • Development Candidate means a Compound that meets the Development Candidate Criteria for the initiation of a Development Program for the treatment of CF, and which is the subject of a notice from Vertex to CFFT that Vertex intends to commence formal pre-clinical development of the Compound in the Field pursuant to the provisions of Section 3.1 hereof.

  • Product Candidate means any pharmaceutical product developed, manufactured and/or tested by or on behalf of the Company that has not received a Regulatory Authorization for commercial distribution other than in connection with pre-clinical or clinical trials.

  • Replacement Candidate means any Candidate Introduced by the Agency to the Client to fill the Engagement following the Introduction of another Candidate whose Engagement either did not commence or was terminated during the first 12 weeks of the Engagement;

  • Collaboration Target means the Initial Collaboration Targets set forth on Exhibit F and any Additional Target or Substitute Target that is selected in accordance with Section 3.3 of this Agreement.

  • Collaboration Compound means any of the following: (a) FG-4592, (b) any HIF Compound (other than FG-4592) that is added to this Agreement pursuant to Section 3.6, and (c) any salts, esters, complexes, chelates, crystalline and amorphous morphic forms, pegylated forms, enantiomers (excluding regioisomers), prodrugs, solvates, metabolites and catabolites of any of the foregoing ((a) or (b)).

  • Candidate means the person Introduced by the Agency to the Client for an Engagement including any officer, employee or other representative of the Candidate if the Candidate is a corporate body, and members of the Agency’s own staff;

  • continuing candidate means any candidate not deemed to be elected, and not excluded,

  • Independent candidate means any candidate who claims not to be affiliated with a political party, and whose name has been certified on the office-type ballot at a general or special election through the filing of a statement of candidacy and nominating petition, as prescribed in section 3513.257 of the Revised Code.

  • Licensed Compounds means: (a) Research Program Active Compounds; (b) Novartis Active Compounds; (c) salts, hydrates, solvates, esters, metabolites, intermediates, stereoisomers and polymorphs of Research Program Active Compounds or Novartis Active Compounds; and (d) prodrugs of Research Program Active Compounds or Novartis Active Compounds (any of the foregoing, a “Licensed Compound”).

  • Licensed Compound means [***].

  • Development Application means the development application identified in Item 5 of Schedule 1 and includes all plans, reports models, photomontages, material boards (as amended supplemented) submitted to the consent authority before the determination of that Development Application.

  • Therapeutic diet means meals served that are soft, low-fat, low-sodium or controlled calorie.

  • Therapeutic Product means a health product categorised as a therapeutic product in the First Schedule to the Act;

  • New Product means the Synology-branded hardware product and Synology-branded accessories contained in the original packaging Customer bought from an authorized Synology distributor or reseller. You may see our “New Product” at Product Support Status.

  • Commercialization or “Commercialize” means activities directed to marketing, promoting, research and development as required, manufacturing for sale, offering for sale, distributing, importing or selling a product, including sub-licensing or sub-contracting of these activities.

  • Lead Compound means any compound of lead other than galena which, when treated in the manner described below, yields to an aqueous solution of hydrochloric acid a quantity soluble lead compound exceeding, when calculated as lead monoxide, five percent of the dry weight of the portion taken analysis.

  • Clinical Study means a Phase I Study, Phase II Study, Phase III Study, as applicable.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Phase I Clinical Study means a human clinical study of a product, the principal purpose of which is a preliminary determination of safety in healthy individuals or patients, as described in 21 C.F.R. 312.21(a).

  • Clinical Studies means human clinical trials for a Licensed Product and any other tests and studies for a Licensed Product in human subjects.

  • Phase III Clinical Study means a trial involving administration of a Compound to sufficient numbers of human patients with the goal of establishing that the Compound is safe and efficacious for its intended use, to define warnings, precautions and adverse reactions that are associated with the drug or label expansion of such Compound, and to be considered as a pivotal study for submission of an NDA.

  • IND means an investigational new drug application filed with the FDA with respect to a Product, or an equivalent application filed with a Regulatory Authority in a country other than the United States to commence a clinical trial of pharmaceutical product.

  • Phase III Clinical Trials means a Clinical Trial for the Product on sufficient numbers of patients to generate safety and efficacy data to support Regulatory Approval in the proposed therapeutic indication, conducted in accordance with current good clinical practices and in accordance with a protocol that has been reviewed by the FDA and reflects any comments or concerns raised by the same.

  • Biosimilar means a biological product that is highly similar to a specific reference biological

  • Phase I Clinical Trial means a human clinical trial that is intended to initially evaluate the safety and/or pharmacological effect of a Product in subjects or that would otherwise satisfy requirements of 21 C.F.R. 312.21(a), or its foreign equivalent.

  • Diagnostic Product means any test or assay for diagnosing or detecting a disease, disorder, medical condition, or symptom.